Primary |
Hypertension |
18.6% |
Hypercholesterolaemia |
17.5% |
Hyperlipidaemia |
16.5% |
Coronary Artery Disease |
14.4% |
Dyslipidaemia |
7.2% |
Myocardial Infarction |
4.1% |
Type 2 Diabetes Mellitus |
4.1% |
Arrhythmia |
3.1% |
Ischaemic Gastritis |
2.1% |
Sleep Disorder |
2.1% |
Aortic Valve Replacement |
1.0% |
Atrial Fibrillation |
1.0% |
Benign Prostatic Hyperplasia |
1.0% |
Blood Cholesterol Increased |
1.0% |
Chronic Lymphocytic Leukaemia |
1.0% |
Depression |
1.0% |
Diabetes Mellitus |
1.0% |
Nephrotic Syndrome |
1.0% |
Osteoporosis |
1.0% |
Pancreatitis Acute |
1.0% |
|
Death |
16.0% |
Rhabdomyolysis |
10.0% |
Pyrexia |
8.0% |
Tendon Rupture |
8.0% |
Hypertension |
6.0% |
Autoimmune Hepatitis |
4.0% |
Breast Disorder Male |
4.0% |
Dyspnoea |
4.0% |
General Physical Health Deterioration |
4.0% |
Liver Disorder |
4.0% |
Lung Infection |
4.0% |
Non-hodgkin's Lymphoma |
4.0% |
Pneumonia |
4.0% |
Sinus Tachycardia |
4.0% |
Syncope |
4.0% |
Type 1 Diabetes Mellitus |
4.0% |
Abasia |
2.0% |
Arrhythmia |
2.0% |
Aspartate Aminotransferase Increased |
2.0% |
Asthma |
2.0% |
|
Secondary |
Hypercholesterolaemia |
22.4% |
Hypertension |
15.8% |
Hyperlipidaemia |
10.6% |
Lipid Metabolism Disorder |
9.2% |
Drug Use For Unknown Indication |
4.3% |
Type 2 Diabetes Mellitus |
4.3% |
Cardiac Failure |
4.0% |
Diabetes Mellitus |
4.0% |
Dyslipidaemia |
3.4% |
Pruritus |
2.9% |
Type Iia Hyperlipidaemia |
2.9% |
Heart Transplant |
2.6% |
Rheumatoid Arthritis |
2.3% |
Coronary Artery Disease |
2.0% |
Prophylaxis |
2.0% |
Low Density Lipoprotein Increased |
1.7% |
Osteoporosis |
1.7% |
Type Iib Hyperlipidaemia |
1.4% |
Gout |
1.1% |
Ischaemic Cardiomyopathy |
1.1% |
|
Rhabdomyolysis |
18.6% |
Pneumonia |
11.4% |
Malaise |
8.6% |
Renal Failure Acute |
7.1% |
Abdominal Discomfort |
5.7% |
Interstitial Lung Disease |
5.7% |
Myalgia |
5.7% |
Pyrexia |
5.7% |
Rash |
4.3% |
Skin Burning Sensation |
4.3% |
Blood Pressure Diastolic Decreased |
2.9% |
Coronary Artery Thrombosis |
2.9% |
Left Ventricular Hypertrophy |
2.9% |
Nervous System Disorder |
2.9% |
Rhinorrhoea |
2.9% |
Sinus Bradycardia |
2.9% |
Abasia |
1.4% |
Androgenetic Alopecia |
1.4% |
Autoimmune Hepatitis |
1.4% |
Blood Alkaline Phosphatase Increased |
1.4% |
|
Concomitant |
Drug Use For Unknown Indication |
22.9% |
Product Used For Unknown Indication |
22.0% |
Hypertension |
11.2% |
Hiv Infection |
5.6% |
Hypercholesterolaemia |
4.9% |
Non-small Cell Lung Cancer |
4.5% |
Hyperlipidaemia |
3.6% |
Rheumatoid Arthritis |
3.4% |
Type 2 Diabetes Mellitus |
3.3% |
Pain |
2.1% |
Renal Transplant |
2.1% |
Cardiac Failure |
2.0% |
Coronary Artery Disease |
1.9% |
Osteoporosis |
1.8% |
Nasopharyngitis |
1.7% |
Diabetes Mellitus |
1.5% |
Hyperparathyroidism Secondary |
1.5% |
Dyslipidaemia |
1.4% |
Atrial Fibrillation |
1.3% |
Bronchitis |
1.2% |
|
Weight Decreased |
9.9% |
Renal Failure Acute |
9.0% |
Vomiting |
9.0% |
Thrombocytopenia |
8.1% |
Myocardial Infarction |
7.2% |
Death |
5.4% |
General Physical Condition |
5.4% |
Liver Disorder |
5.4% |
Rhabdomyolysis |
4.5% |
Cardiac Failure |
3.6% |
Hepatic Function Abnormal |
3.6% |
Intussusception |
3.6% |
Myalgia |
3.6% |
Pulmonary Embolism |
3.6% |
Somnolence |
3.6% |
Visual Acuity Reduced |
3.6% |
Atrial Fibrillation |
2.7% |
Drug Exposure During Pregnancy |
2.7% |
Drug Interaction |
2.7% |
Hypotension |
2.7% |
|
Interacting |
Angina Pectoris |
16.7% |
Dyslipidaemia |
16.7% |
Hypertension |
16.7% |
Nausea |
16.7% |
Type 2 Diabetes Mellitus |
16.7% |
Vomiting |
16.7% |
|
|